Alexandre Cammarata-Mouchtouris

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “221 Elexacaftor-tezacaftor-ivacaftor did not curtail sputummyeloperoxidase in a cohort of adults with cystic fibrosis”.

221 Elexacaftor-tezacaftor-ivacaftor did not curtail sputummyeloperoxidase in a cohort of adults with cystic fibrosis

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01151-7

N/A

0DataRank · unranked

0 citations

Diego Moncada Giraldo, Alexandre Cammarata-Mouchtouris, R. Tirouvanziam, J. Chandler, G. Collins

Symptoms and quality of life in adults with cystic fibrosis: A cross-sectional analysis of the InSPIRe:CF trial

Journal of Cystic Fibrosis(2024)10.1016/j.jcf.2024.03.005

N/A

0DataRank · unranked

8 citations

Jane Lowers, Alexandre Cammarata-Mouchtouris, Elisabeth P. Dellon, Anne M. Fitzpatrick, Dio Kavalieratos +1 more

Symptom factors and their clinical correlates among adults with cystic fibrosis

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.07.001

N/A

0DataRank · unranked

1 citations

Scott Gillespie, Jane Lowers, Andrew Jergel, Elisabeth P. Dellon, Alexandre Cammarata-Mouchtouris +3 more